Northern Oak Wealth Management Inc Aurinia Pharmaceuticals Inc. Transaction History

Northern Oak Wealth Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 24, 2022	SELL	$10.05 - $22.48 $2,512 - $5,620	-250 Reduced 7.69%	3,000 $37,000
Q4 2021 Feb 16, 2022	SELL	$17.78 - $33.08 $11,557 - $21,502	-650 Reduced 16.67%	3,250 $74,000
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $9,837 - $21,195	-900 Reduced 18.75%	3,900 $86,000
Q2 2021 Aug 17, 2021	BUY	$10.0 - $14.52 $18,000 - $26,136	1,800 Added 60.0%	4,800 $62,000
Q1 2021 May 14, 2021	BUY	$12.3 - $18.73 $36,900 - $56,190	3,000 New	3,000 $39,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Northern Oak Wealth Management Inc, based on Form 13F filings with the SEC.

Stay updated on Northern Oak Wealth Management Inc with notifications on news.